1	Hypoxia-inducible	_	JJ	_	_	4	NMOD	_	_
2	factor	_	NN	_	_	4	NMOD	_	_
3	1	_	CD	_	_	4	NMOD	_	_
4	activation	_	NN	_	_	8	VMOD	_	_
5	by	_	IN	_	_	4	NMOD	_	_
6	aerobic	_	JJ	_	_	7	NMOD	_	_
7	glycolysis	_	NN	_	_	5	PMOD	_	_
8	implicates	_	VBZ	_	_	0	ROOT	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	Warburg	_	NN	_	_	11	NMOD	_	_
11	effect	_	NN	_	_	8	VMOD	_	_
12	in	_	IN	_	_	8	VMOD	_	_
13	carcinogenesis	_	NN	_	_	12	PMOD	_	_
14	.	_	.	_	_	8	P	_	_
		
1	Cancer	_	NN	_	_	2	NMOD	_	_
2	cells	_	NNS	_	_	3	VMOD	_	_
3	display	_	VBP	_	_	0	ROOT	_	_
4	high	_	JJ	_	_	5	NMOD	_	_
5	rates	_	NNS	_	_	3	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	aerobic	_	JJ	_	_	8	NMOD	_	_
8	glycolysis	_	NN	_	_	6	PMOD	_	_
9	,	_	,	_	_	5	P	_	_
10	a	_	DT	_	_	11	NMOD	_	_
11	phenomenon	_	NN	_	_	5	APPO	_	_
12	known	_	VBN	_	_	11	APPO	_	_
13	historically	_	RB	_	_	12	VMOD	_	_
14	as	_	IN	_	_	12	VMOD	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	Warburg	_	NN	_	_	17	NMOD	_	_
17	effect	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	3	P	_	_
		
1	Lactate	_	NN	_	_	11	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	pyruvate	_	NN	_	_	2	CONJ	_	_
4	,	_	,	_	_	1	P	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	end	_	NN	_	_	7	NMOD	_	_
7	products	_	NNS	_	_	1	APPO	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	glycolysis	_	NN	_	_	8	PMOD	_	_
10	,	_	,	_	_	1	P	_	_
11	are	_	VBP	_	_	0	ROOT	_	_
12	highly	_	RB	_	_	11	VMOD	_	_
13	produced	_	VBN	_	_	11	VC	_	_
14	by	_	IN	_	_	13	VMOD	_	_
15	cancer	_	NN	_	_	16	NMOD	_	_
16	cells	_	NNS	_	_	14	PMOD	_	_
17	even	_	RB	_	_	18	PMOD	_	_
18	in	_	IN	_	_	13	VMOD	_	_
19	the	_	DT	_	_	18	DEP	_	_
20	presence	_	NN	_	_	18	DEP	_	_
21	of	_	IN	_	_	18	DEP	_	_
22	oxygen	_	NN	_	_	18	PMOD	_	_
23	.	_	.	_	_	11	P	_	_
		
1	Hypoxia-induced	_	JJ	_	_	3	NMOD	_	_
2	gene	_	NN	_	_	3	NMOD	_	_
3	expression	_	NN	_	_	7	VMOD	_	_
4	in	_	IN	_	_	3	NMOD	_	_
5	cancer	_	NN	_	_	6	NMOD	_	_
6	cells	_	NNS	_	_	4	PMOD	_	_
7	has	_	VBZ	_	_	0	ROOT	_	_
8	been	_	VBN	_	_	7	VC	_	_
9	linked	_	VBN	_	_	8	VC	_	_
10	to	_	TO	_	_	9	VMOD	_	_
11	malignant	_	JJ	_	_	12	NMOD	_	_
12	transformation	_	NN	_	_	10	PMOD	_	_
13	.	_	.	_	_	7	P	_	_
		
1	Here	_	RB	_	_	3	VMOD	_	_
2	we	_	PRP	_	_	3	VMOD	_	_
3	provide	_	VBP	_	_	0	ROOT	_	_
4	evidence	_	NN	_	_	3	VMOD	_	_
5	that	_	IN	_	_	4	NMOD	_	_
6	lactate	_	NN	_	_	9	VMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	pyruvate	_	NN	_	_	7	CONJ	_	_
9	regulate	_	VBP	_	_	5	SUB	_	_
10	hypoxia-inducible	_	JJ	_	_	12	NMOD	_	_
11	gene	_	NN	_	_	12	NMOD	_	_
12	expression	_	NN	_	_	9	VMOD	_	_
13	independently	_	RB	_	_	9	VMOD	_	_
14	of	_	IN	_	_	13	AMOD	_	_
15	hypoxia	_	NN	_	_	14	PMOD	_	_
16	by	_	IN	_	_	9	VMOD	_	_
17	stimulating	_	VBG	_	_	16	PMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	accumulation	_	NN	_	_	17	VMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	hypoxia-inducible	_	JJ	_	_	23	NMOD	_	_
22	Factor	_	NN	_	_	23	NMOD	_	_
23	1alpha	_	NN	_	_	20	PMOD	_	_
24	(	_	(	_	_	25	P	_	_
25	HIF-1alpha	_	NN	_	_	23	PRN	_	_
26	)	_	)	_	_	25	P	_	_
27	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	18	VMOD	_	_
2	human	_	JJ	_	_	3	NMOD	_	_
3	gliomas	_	NNS	_	_	1	PMOD	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	other	_	JJ	_	_	8	NMOD	_	_
6	cancer	_	NN	_	_	8	NMOD	_	_
7	cell	_	NN	_	_	8	NMOD	_	_
8	lines	_	NNS	_	_	4	CONJ	_	_
9	,	_	,	_	_	18	P	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	accumulation	_	NN	_	_	18	VMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	HIF-1alpha	_	NN	_	_	14	NMOD	_	_
14	protein	_	NN	_	_	12	PMOD	_	_
15	under	_	IN	_	_	11	NMOD	_	_
16	aerobic	_	JJ	_	_	17	NMOD	_	_
17	conditions	_	NNS	_	_	15	PMOD	_	_
18	requires	_	VBZ	_	_	0	ROOT	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	metabolism	_	NN	_	_	18	VMOD	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	glucose	_	NN	_	_	21	PMOD	_	_
23	to	_	TO	_	_	20	NMOD	_	_
24	pyruvate	_	NN	_	_	23	PMOD	_	_
25	that	_	WDT	_	_	26	VMOD	_	_
26	prevents	_	VBZ	_	_	20	NMOD	_	_
27	the	_	DT	_	_	29	NMOD	_	_
28	aerobic	_	JJ	_	_	29	NMOD	_	_
29	degradation	_	NN	_	_	26	VMOD	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	HIF-1alpha	_	NN	_	_	32	NMOD	_	_
32	protein	_	NN	_	_	30	PMOD	_	_
33	,	_	,	_	_	26	P	_	_
34	activates	_	VBZ	_	_	26	COORD	_	_
35	HIF-1	_	NN	_	_	38	NMOD	_	_
36	DNA	_	NN	_	_	38	NMOD	_	_
37	binding	_	NN	_	_	38	NMOD	_	_
38	activity	_	NN	_	_	34	VMOD	_	_
39	,	_	,	_	_	34	P	_	_
40	and	_	CC	_	_	34	COORD	_	_
41	enhances	_	VBZ	_	_	40	CONJ	_	_
42	the	_	DT	_	_	43	NMOD	_	_
43	expression	_	NN	_	_	41	VMOD	_	_
44	of	_	IN	_	_	43	NMOD	_	_
45	several	_	JJ	_	_	47	NMOD	_	_
46	HIF-1-activated	_	JJ	_	_	47	NMOD	_	_
47	genes	_	NNS	_	_	44	PMOD	_	_
48	including	_	VBG	_	_	47	NMOD	_	_
49	erythropoietin	_	NN	_	_	48	PMOD	_	_
50	,	_	,	_	_	49	P	_	_
51	vascular	_	JJ	_	_	54	NMOD	_	_
52	endothelial	_	JJ	_	_	54	NMOD	_	_
53	growth	_	NN	_	_	54	NMOD	_	_
54	factor	_	NN	_	_	49	COORD	_	_
55	,	_	,	_	_	54	P	_	_
56	glucose	_	NN	_	_	57	NMOD	_	_
57	transporter	_	NN	_	_	54	COORD	_	_
58	3	_	CD	_	_	57	NMOD	_	_
59	,	_	,	_	_	57	P	_	_
60	and	_	CC	_	_	57	COORD	_	_
61	aldolase	_	NN	_	_	62	NMOD	_	_
62	A	_	NN	_	_	60	CONJ	_	_
63	.	_	.	_	_	18	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	findings	_	NNS	_	_	3	VMOD	_	_
3	support	_	VBP	_	_	0	ROOT	_	_
4	a	_	DT	_	_	6	NMOD	_	_
5	novel	_	JJ	_	_	6	NMOD	_	_
6	role	_	NN	_	_	3	VMOD	_	_
7	for	_	IN	_	_	6	NMOD	_	_
8	pyruvate	_	NN	_	_	7	PMOD	_	_
9	in	_	IN	_	_	6	NMOD	_	_
10	metabolic	_	JJ	_	_	11	NMOD	_	_
11	signaling	_	NN	_	_	9	PMOD	_	_
12	and	_	CC	_	_	3	COORD	_	_
13	suggest	_	VBP	_	_	12	CONJ	_	_
14	a	_	DT	_	_	15	NMOD	_	_
15	mechanism	_	NN	_	_	13	VMOD	_	_
16	by	_	IN	_	_	23	VMOD	_	_
17	which	_	WDT	_	_	16	PMOD	_	_
18	high	_	JJ	_	_	19	NMOD	_	_
19	rates	_	NNS	_	_	23	VMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	aerobic	_	JJ	_	_	22	NMOD	_	_
22	glycolysis	_	NN	_	_	20	PMOD	_	_
23	can	_	MD	_	_	15	NMOD	_	_
24	promote	_	VB	_	_	23	VC	_	_
25	the	_	DT	_	_	27	NMOD	_	_
26	malignant	_	JJ	_	_	27	NMOD	_	_
27	transformation	_	NN	_	_	24	VMOD	_	_
28	and	_	CC	_	_	27	COORD	_	_
29	survival	_	NN	_	_	28	CONJ	_	_
30	of	_	IN	_	_	27	NMOD	_	_
31	cancer	_	NN	_	_	32	NMOD	_	_
32	cells	_	NNS	_	_	30	PMOD	_	_
33	.	_	.	_	_	3	P	_	_
		
